Kai Ma

Dr. Kai Ma


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 April 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
LWLuxi Wang
Luxi Wang
LLLing Liu
Ling Liu
CHChao Han
Chao Han
HJHaiyang Jiang
Haiyang Jiang
KMKai Ma
Kai Ma
TWTao Wang
Tao Wang
(1) Background: Parkinson’s disease (PD) is the most common movement disorder. Imbalanced protein homeostasis and α-syn aggregation are involved in PD pathogenesis. Autophagy is related to the occurrence and development of PD and can be regulated by histone deacetylases (HDACs). Various inhibitors of HDACs exert neuroprotective effects within in vitro and in vivo models of PD. HDAC4, a class Ⅱ HDAC, colocalizes with α-synuclein and ubiquitin in Lewy bodies and also accumulates in the nuclei of dopaminergic neurons in PD models. (2) Methods: In the present study, the gene expression profile of HDACs from two previously reported datasets in the GEO database was analyzed, and the RNA levels of HDAC4 in brain tissues were compared between PD patients and healthy controls. In vitro, SH-SY5Y cells transfected with HDAC4 shRNA or pretreated with mc1568 were treated with 1 μM of rotenone for 24 h. Then, the levels of α-syn, LC3, and p62 were detected using Western blot analysis and immunofluorescent staining, and cell viabilities were detected using Cell Counting Kit-8 (CCK-8). (3) Results: HDAC4 was highly expressed in PD substantia nigra and locus coeruleus. Mc1568, an inhibitor of HDAC4, decreased α-synuclein levels in rotenone-treated SH-SY5Y cells in a concentration-dependent manner and activated autophagy, which was impaired by rotenone. The knockdown of HDAC4 reversed rotenone-induced α-syn accumulation in SH-SY5Y cells and protected the neurons by enhancing autophagy. (4) Conclusions: HDAC4 is a potential therapeutic target for PD. The inhibition of HDAC4 by mc1568 or a gene block can reduce α-syn levels by regulating the autophagy process in PD. Mc1568 is a promising therapeutic agent for PD and other disorders related to α-syn accumulation.

24 March 2026 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
HZHaohan Zhang
Haohan Zhang
RLRong Li
Rong Li
YJYuxiang Jiao
Yuxiang Jiao
YNYuxin Niu
Yuxin Niu
XHXiaodi Hao
Xiaodi Hao
JZJie-Wen Zhang
Jie-Wen Zhang

27 March 2026 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
SCShuai Chen
Shuai Chen
YNYu-Xin Niu
Yu-Xin Niu
CLChen-Hong Li
Chen-Hong Li
XXXue-Feng Xiang
Xue-Feng Xiang
JSJing-Yu Shao
Jing-Yu Shao
JZJie-Wen Zhang
Jie-Wen Zhang

25 November 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
LLLeishen Li
Leishen Li
FXFangfang Xu
Fangfang Xu
HDHongyan Duan
Hongyan Duan
JQJunjia Qi
Junjia Qi
JZJingyi Zhang
Jingyi Zhang
KMKai Ma
Kai Ma
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with complex underlying mechanisms. PANoptosis, a newly defined form of programm

18 February 2026 in Autonomic Neuroscience
Verified
Journal Article
Closed access
SCShuai Chen
Shuai Chen
YSYu Shen
Yu Shen
JSJingyu Shao
Jingyu Shao
RLRong Li
Rong Li
XHXiaodi Hao
Xiaodi Hao
JZJie-Wen Zhang
Jie-Wen Zhang